Overview
- 43 inspections across 40 sites are on record.
- 76 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-03.
At a glance
Inspections
43
Sites
40
Observations
76
Career since
Aug 2010
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Jiangsu Center for Safety Evaluation of Drugs | 3 Apr 2026 | Human Drugs | On file |
| Tianjin Institute of Pharmaceutical Research New Drug Evaluation Co. Ltd | 23 May 2025 | Human Drugs | On file |
| SAFE Medical Technology Co., LtD. | 16 May 2025 | Human Drugs | On file |
| Health Partners Neuroscience Center Research and Innovation | 21 Mar 2025 | Human Drugs | View 483 → |
| Palamur Biosciences Private Limited | 27 Jan 2025 | Human Drugs | View 483 → |
Sites inspected
Jiangsu Center for Safety Evaluation of DrugsNanjing, China1 insp.
Tianjin Institute of Pharmaceutical Research New Drug Evaluation Co. LtdTanjin, China1 insp.
SAFE Medical Technology Co., LtD.Langfang, China1 insp.
Health Partners Neuroscience Center Research and InnovationSaint Paul, United States1 insp.
Palamur Biosciences Private LimitedMahabubnagar, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Zhou Chen28 shared
Hugh M Mcclure9 shared
Carmen Y Fisher5 shared
Byungja E Marciante3 shared
Joanne M Schlossin3 shared
Debra L Boyd Seale3 shared
Andrew R Wasko2 shared
Deborah A Greco2 shared
Marijo B Kambere2 shared
Marcia A Worley2 shared
Full investigator report
Get the verbatim findings behind Mark J Seaton's 76 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site